Brought to you by GSK

Please join our presentation “Managing Immune-related Adverse Events with Checkpoint Inhibitors” on Tuesday, April 27th at 3:00 PM. 

Immune checkpoint inhibitors play an important role in the treatment of many different cancers and have a distinct adverse event profile. Practical understanding of immune-related adverse events (irAEs) associated with checkpoint inhibitors is essential to the identification and proper management of toxicities and ensuring continuity of treatment.  

Please join our presentation “Managing Immune-related Adverse Events with Checkpoint Inhibitors” on Tuesday, April 27th at 3:00 PM. This GSK-sponsored presentation will provide oncology nurses and nurse practitioners with evidence-based guidance on monitoring and managing irAEs in patients with cancer treated with checkpoint inhibitors